Detalles de la búsqueda
1.
Assessment of an optimized manufacturing process for inactivated quadrivalent influenza vaccine: a phase III, randomized, double-blind, safety and immunogenicity study in children and adults.
BMC Infect Dis
; 18(1): 186, 2018 04 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-29669531
2.
Immunogenicity and Safety of an AS03-Adjuvanted H7N9 Pandemic Influenza Vaccine in a Randomized Trial in Healthy Adults.
J Infect Dis
; 214(11): 1717-1727, 2016 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27609809
3.
Vaccine for prevention of mild and moderate-to-severe influenza in children.
N Engl J Med
; 369(26): 2481-91, 2013 Dec 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-24328444
4.
Immunogenicity and Safety of an EB66 Cell-Culture-Derived Influenza A/Indonesia/5/2005(H5N1) AS03-Adjuvanted Vaccine: A Phase 1 Randomized Trial.
J Infect Dis
; 212(4): 531-41, 2015 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25722291
5.
AS03B-adjuvanted H5N1 influenza vaccine in children 6 months through 17 years of age: a phase 2/3 randomized, placebo-controlled, observer-blinded trial.
J Infect Dis
; 211(5): 801-10, 2015 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25293368
6.
Protection against varicella with two doses of combined measles-mumps-rubella-varicella vaccine versus one dose of monovalent varicella vaccine: a multicentre, observer-blind, randomised, controlled trial.
Lancet
; 383(9925): 1313-1324, 2014 Apr 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-24485548
7.
Relative efficacy of AS03-adjuvanted pandemic influenza A(H1N1) vaccine in children: results of a controlled, randomized efficacy trial.
J Infect Dis
; 210(4): 545-57, 2014 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-24652494
8.
A historically-controlled Phase III study in adults to characterize the acceptability of a process change for manufacturing inactivated quadrivalent influenza vaccine.
BMC Infect Dis
; 14: 133, 2014 Mar 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-24606983
9.
A randomized trial of candidate inactivated quadrivalent influenza vaccine versus trivalent influenza vaccines in children aged 3-17 years.
J Infect Dis
; 207(12): 1878-87, 2013 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-23470848
10.
Experimental dengue virus challenge of human subjects previously vaccinated with live attenuated tetravalent dengue vaccines.
J Infect Dis
; 207(5): 700-8, 2013 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23225894
11.
Immunogenicity and safety of an inactivated quadrivalent influenza vaccine candidate: a phase III randomized controlled trial in children.
J Infect Dis
; 208(4): 544-53, 2013 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-23847058
12.
A chimeric haemagglutinin-based universal influenza virus vaccine boosts human cellular immune responses directed towards the conserved haemagglutinin stalk domain and the viral nucleoprotein.
EBioMedicine
; 104: 105153, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38805853
13.
Effective and safe transfer of maternal antibodies persisting two months postpartum following maternal immunization with different doses of recombinant pertussis-containing vaccines.
Vaccine
; 42(2): 383-395, 2024 Jan 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38061956
14.
Immunogenicity, reactogenicity and safety of an inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine: a phase III, randomized trial in adults aged ≥18 years.
BMC Infect Dis
; 13: 343, 2013 Jul 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-23883186
15.
A phase 2 randomized controlled dose-ranging trial of recombinant pertussis booster vaccines containing genetically inactivated pertussis toxin in pregnant women.
Vaccine
; 41(31): 4541-4553, 2023 07 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37330371
16.
Vaccine for prevention of influenza in children.
N Engl J Med
; 370(12): 1167-8, 2014 03 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-24645953
17.
Interference and facilitation between dengue serotypes in a tetravalent live dengue virus vaccine candidate.
J Infect Dis
; 204(3): 442-50, 2011 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-21742844
18.
Vital sign predictors of severe influenza among children in an emergent care setting.
PLoS One
; 17(8): e0272029, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35960719
19.
Association Between Hemagglutination Inhibition Antibody Titers and Protection Against Reverse-Transcription Polymerase Chain Reaction-Confirmed Influenza Illness in Children 6-35 Months of Age: Statistical Evaluation of a Correlate of Protection.
Open Forum Infect Dis
; 9(2): ofab477, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-35083365
20.
Reactogenicity, safety, and immunogenicity of chimeric haemagglutinin influenza split-virion vaccines, adjuvanted with AS01 or AS03 or non-adjuvanted: a phase 1-2 randomised controlled trial.
Lancet Infect Dis
; 22(7): 1062-1075, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35461522